Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-68.99	3.16	10.19
Graham Fair Price	41.43	0.43	0.30
PEG	84.93	0.03	-0.02
Price/Book	-11.43	0.22	0.25
Price/Cash Flow	56.51	-3.14	-7.21
Prices/Earnings	-55.72	3.31	7.48
Price/Sales	-55.72	0.52	1.18
Price/FCF	56.51	-3.14	-7.21
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.44	0.44
Operating Margin	0.00	0.07	0.07
ROA	100.00	0.01	< 0.005
ROE	< 0.005	0.02	100.00
ROIC	< 0.005	0.02	92.57
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.26	-0.13	94.87
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	2.12	1.00	-52.92
EPS QOQ	4.11	0.98	-76.05
FCF QOQ	0.03	-1.04	3621.45
Revenue QOQ	-0.52	1.00	93.94
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	303.14	151.57	-50.00
Days Sales Outstanding (DSO)	72.56	48.08	-33.74
Inventory Turnover	0.30	0.59	100.00
Debt/Capitalization	0.15	0.18	21.15
Quick Ratio	0.85	0.97	14.50
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.70	0.70	< 0.005
Cash	0.15	0.15	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	-0.02	-0.05	-103.68
Revenue	0.15	0.30	100.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.85	1.85	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.10	0.56	463.91
Naive Interpretation	Member

06 - Financial Health · Weak

Rating